Who we are
NovaGo Therapeutics is a development stage biotech company focused on human antibody therapeutics targeting blood vessel and nerve growth.
read moreDIABETIC RETINOPATHY
NovaGo is planning to initiate clinical development for its lead molecule as a novel treatment for diabetic retinopathy (DR), the leading cause of blindness in adults. DR is a common complication of Type 1 and Type 2 Diabetes.
read more